Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Aug 26, 2014; 6(8): 847-854
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.847
Pseudoexfoliation syndrome and cardiovascular diseases
Georgios K Andrikopoulos, Dimitrios K Alexopoulos, Sotirios P Gartaganis
Sotirios P Gartaganis, Georgios K Andrikopoulos, Department of Ophthalmology, University of Patras Medical School, 26504 Patras, Greece
Dimitrios K Alexopoulos, Department of Internal Medicine, Division of Cardiology, University of Patras Medical School, 26504 Patras, Greece
Author contributions: Andrikopoulos GK, Alexopoulos DK and Gartaganis SP contributed to this paper.
Correspondence to: Sotirios P Gartaganis, MD, Emeritus Professor, Department of Ophthalmology, University of Patras, Medical School, 26504 Rion, Patras, Greece. s.gartag@med.upatras.gr
Telephone: +30-61-0271647 Fax: +30-61-0271647
Received: December 18, 2013
Revised: April 9, 2014
Accepted: June 10, 2014
Published online: August 26, 2014
Abstract

Pseudoexfoliation (PEX) syndrome is a well-recognized late-onset disease caused by a generalized fibrillopathy. It is linked to a broad spectrum of ocular complications including glaucoma and perioperative problems during cataract surgery. Apart from the long-known intraocular manifestations, PEX deposits have been found in a variety of extraocular locations and they appear to represent a systemic process associated with increased cardiovascular and cerebrovascular morbidity. However, as published results are inconsistent, the clinical significance of the extraocular PEX deposits remains controversial. Identification of PEX deposits in the heart and the vessel wall, epidemiologic studies, as well as, similarities in pathogenetic mechanisms have led to the hypothesis of a possible relation between fibrillar material and cardiovascular disease. Recent studies suggest that PEX syndrome is frequently linked to impaired heart and blood vessels function. Systemic and ocular blood flow changes, altered parasympathetic vascular control and baroreflex sensitivity, increased vascular resistance and decreased blood flow velocity, arterial endothelial dysfunction, high levels of plasma homocysteine and arterial hypertension have all been demonstrated in PEX subjects. Common features in the pathogenesis of both atherosclerosis and PEX, like oxidative stress and inflammation and a possible higher frequency of abdominal aorta aneurysm in PEX patients, could imply that these grey-white deposits and cardiovascular disorders are related or reflect different manifestations of the same process.

Keywords: Pseudoexfoliation, Cardiovascular disease, Cerebrovascular disease, Coronary artery disease, Homocysteine

Core tip: Although much remains to be clarified concerning causes, pathogenesis and systemic role of pseudoexfoliation aggregations, there is accumulating epidemiologic, clinical and laboratory evidence that this well-described clinical entity may occur as part of a systemic disorder with cardiovascular implications. The present review aims to summarize current knowledge on cardiovascular complications which have been associated with these suspicious whitish-gray deposits.